Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction CancerJianming Xu, Hongyu Zhang, Shundong Cang et al.|JAMA|2023Cited by 384
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phasesYe Guo, Jin Li, Weijie Zhang et al.|European Journal of Cancer|2022Cited by 57